Back

The effects of female sex hormones, the estrus cycle, and ischemic preconditioning on myocardial infarction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Basic science - cardiac disease 2 Cardiac Diseases HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Tetiana Pylova

Institute of Medicine - Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

6 More presentations in this session

Presentation thumbnail
Evaluation of carriers of pathogenic variants in KCNH2 gene
Doctor R. Lorca (Oviedo, ES)
Abstract Slides Video
Presentation thumbnail
Perfused rat heart model for studies of takotsubo syndrome
Doctor A. Nejat (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Development of spontaneous multifocal metastatic mammary tumors induces cardiac dysfunction in mice.
Doctor P. Pokreisz (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Engineered epicardial cells from human embryonic stem cells promote engraftment and maturation of human cardiac progenitor cells in the rodent and porcine model
Doctor G. Musa (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Development and diagnostic utility of an immunoturbidimetric NT-proBNP assay based on antibodies targeting glycosylation-free regions of NT-proBNP
Doctor A. Havelka (Moss, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Basic science - cardiac disease 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Impact of gender-related differences in outcomes in acute myocardial infarction: non-obstructive coronary arteries versus obstructive coronary arteries
thumbnail
Congress Presentation
A newly developed small-molecule ErbB4 agonist reduces reactive cardiac fibrosis and adverse ventricular remodelling after myocardial infarction in a sex-specific manner.
thumbnail
Congress Presentation
Estrogen receptors in the female heart and in a rat model of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources